Take an EXTRA 30% OFF any initial
Program purchase — limited time only!

Shop our products & programs

• Doctor-formulated
• Natural & effective
• 100% guaranteed
• Made in FDA-inspected labs

Silymarin/Milk Thistle

Silymarin/Milk Thistle

Our Silymarin/Milk Thistle supports healthy liver function — the body’s detoxifying organ that disables harmful toxins. When damaged, the liver’s ability to eliminate toxins may be severely impaired. Our Silymarin/Milk Thistle supports and enhances healthy liver function in three ways as seen below.

How will Milk Thistle help me?

  • Prevents harmful toxins from entering the cells
  • Provides antioxidants which protect against the potentially damaging free radicals the liver naturally produces
  • Stimulates damaged liver cells to regenerate more quickly, repairing damaged cells

Our Milk Thistle is:

  • Formulated without milk/dairy, eggs, peanuts, tree nuts, fish, shellfish, wheat, yeast, corn, or artificial preservatives, colors, sweeteners or flavors.
  • Manufactured in a facility validated by NSF International to meet or exceed all governmental requirements for Good Manufacturing Practices (the FDA's GMPs).

These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease.
Silymarin/Milk Thistle Ingredients

Product References

Allain, H, Schuck, S, Lebreton, S, Strenge-Hesse, A, Braun, W, Gandon, JM, Brissot, P. Aminotransferase levels and silymarin in de novo tacrine-treated patients with Alzheimer's disease. Dement Geriatr Cogn Disord 1999;10:181-5.

Bass, NM. Is there any use for nontraditional or alternative therapies in patients with chronic liver disease? [In Process Citation]. Curr Gastroenterol Rep 1999;1:50-6.

Berkson, BM. A conservative triple antioxidant approach to the treatment of hepatitis C. Combination of alpha lipoic acid (thioctic acid), silymarin, and selenium: three case histories. Med Klin 1999;94 Suppl 3:84-9.

Edwards, J, Grange, LL, Wang, M, Reyes, E. Fetoprotectivity of the flavanolignan compound siliphos against ethanol- inducedtoxicity [In Process Citation]. Phytother Res 2000;14:517-21.

Farghali, H, Kamenikova, L, Hynie, S, Kmonickova, E. Silymarin effects on intracellular calcuim and cytotoxicity: a study in perfused rat hepatocytes after oxidative stress injury. Pharmacol Res 2000;41:231-7.

Flora, K, Hahn, M, Rosen, H, Benner, K. Milk thistle (Silybum marianum) for the therapy of liver disease [see comments]. Am J Gastroenterol 1998;93:139-43.

Kropacova, K, Misurova, E, Hakova, H. Protective and therapeutic effect of silymarin on the development of latent liver damage. Radiats Biol Radioecol 1998;38:411-5.

Par, A, Roth, E, Rumi, G, Jr., Kovacs, Z, Nemes, J, Mozsik, G. [Oxidative stress and antioxidant defense in alcoholic liver disease and chronic hepatitis C]. Orv Hetil 2000;141:1655-9.

Zhao, J, Sharma, Y, Agarwal, R. Significant inhibition by the flavonoid antioxidant silymarin against 12-O-tetradecanoylphorbol 13-acetate-caused modulation of antioxidant and inflammatory enzymes, and cyclooxygenase 2 and interleukin-1alpha expression in SENCAR mouse epidermis: implications in the prevention of stage I tumor promotion. Mol Carcinog 1999;26:321-33.

Zhao, J, Agarwal, R. Tissue distribution of silibinin, the major active constituent of silymarin, in mice and its association with enhancement of phase II enzymes: implications in cancer chemoprevention. Carcinogenesis 1999;20:2101-8.

There are currently no reviews for this item.